Investing.com -- The White House has requested the resignation of a top aide to U.S. Food and Drug Administration Commissioner Marty Makary, according to a Politico report on Friday that cited administration officials.
The report stated that Makary had attempted to promote Sanjula Jain-Nagpal, a policy and research staffer at the FDA, without White House approval. In response, the White House emailed leadership at the Department of Health and Human Services on Thursday requesting her resignation.
According to Politico, Makary resisted the request to remove Jain-Nagpal from the agency. An HHS spokesperson told Reuters that Jain-Nagpal remains an FDA employee.
Jain-Nagpal was appointed in April as the associate director of policy and research strategy in the FDA commissioner’s office. She previously served as a professor at Johns Hopkins University and regularly appears on Makary’s "FDA Direct" podcast.
This development occurs amid growing tensions between Makary and leadership at both HHS and the White House in recent weeks. Media reports indicate there have been other controversies involving staff Makary brought into the agency.
The Wall Street Journal reported last week that Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed reducing Makary’s role.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.








